Connect with us
Abilify
Company
Indications
- irritability associated with autistic disorder (ages 6-17 years)
- treatment of acute manic or mixed episodes associated with Bipolar I Disorder in adults and pediatric patients aged 10 to 17 years
- adjunctive therapy added to lithium or valproate in the short-term treatment of episodes associated with Bipolar Disorder, manic or mixed
- Schizophrenia
- Schizophrenia including maintenance up to 26 weeks
- Acute manic or mixed episodes associated with Bipolar Disorder
- Maintenance therapy in Bipolar I Disorder
- (intramuscular) agitation associated with Schizophrenia or Bipolar Disorder, manic or mixed
- treatment of Schizophrenia in adolescents aged 13-17
- adjunctive treatment of Major Depressive Disorder